HM
AEGR

HealthCor Management’s Aegerion Pharmaceuticals AEGR Stock Holding History

HealthCor Management’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-463,700
Closed -$15.5M – 67
2014
Q3 		$15.5M Buy
+463,700
New +$14.4M 0.79% 32
2014
Q2 		– Sell
-24,800
Closed -$1.15M – 76
2014
Q1 		$1.15M Sell
24,800
-825,200
-97% -$48.4M 0.07% 56
2013
Q4 		$60.3M Buy
850,000
+425,000
+100% +$32.5M 3.66% 8
2013
Q3 		$36.4M Buy
425,000
+298,300
+235% +$25.3M 1.95% 21
2013
Q2 		$8.03M Buy
+126,700
New +$6.73M 0.49% 42

Other funds holding AEGR

SCM
Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

HealthCor Management's AEGR Position: Q4 2014 in Review

HealthCor Management sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2014, closing a stake of 463,700 shares — an estimated $15.5M sold.

HealthCor Management first reported a position in AEGR in Q2 2013 and held it in 5 quarters. The position peaked at $60.3M in Q4 2013. 95 funds tracked by Wall St. Rank hold AEGR as of Q4 2014.

  • HealthCor Management reported no remaining Aegerion Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • HealthCor Management sold 463,700 Aegerion Pharmaceuticals shares in Q4 2014, an estimated $15.5M.
  • HealthCor Management first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 5 quarters.
  • HealthCor Management's Aegerion Pharmaceuticals position peaked at $60.3M in Q4 2013.
  • 95 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2014.

Based on HealthCor Management's 13F filing for Q4 2014, filed 17 Feb 2015.